Effects of medetomidine and midazolam alone or in combination on the metabolic and neurohormonal responses in healthy cats

Canadian Journal of Veterinary Research

Volumn 72, Issue 4, 2008, Pages 332-339

  Kanda, Teppei ^a   Hikasa, Yoshiaki ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; FATTY ACID; GLUCAGON; GLUCOSE; HYDROCORTISONE; INSULIN; MEDETOMIDINE; MIDAZOLAM MALEATE; NORADRENALIN;

ADRENALIN BLOOD LEVEL; ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; BREATHING RATE; CAT; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MECHANISM; FATTY ACID BLOOD LEVEL; GLUCAGON BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HEART RATE; HORMONE RESPONSE; HYDROCORTISONE BLOOD LEVEL; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; METABOLIC REGULATION; MONOTHERAPY; NONHUMAN; NORADRENALIN BLOOD LEVEL; RECTUM TEMPERATURE; RECUMBENCY;

ADRENERGIC ALPHA-AGONISTS; ANIMALS; AREA UNDER CURVE; BLOOD GLUCOSE; CATS; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; EPINEPHRINE; FATTY ACIDS, NONESTERIFIED; FEMALE; HEART RATE; HYPNOTICS AND SEDATIVES; INSULIN; MALE; MEDETOMIDINE; MIDAZOLAM; NOREPINEPHRINE; RESPIRATION;

EID: 48749091353     PISSN: 08309000     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Greene SA. Pros and cons of using alpha-2 agonists in small animal anesthesia practice. Clin Tech Small Anim Pract 1999;14: 10-14.
2. Hayashi K, Nishimura R, Yamaki A, et al. Cardiopulmonary effects of medetomidine, medetomidine-midazolam and medetomidine-midazolam-atipamezole in dogs. J Vet Med Sci 1995;57:99-104.
3. Ambrisko TD, Hikasa Y. Neurohormonal and metabolic effects of medetomidine compared with xylazine in beagle dogs. Can J Vet Res 2002;66:42-49.
4. Lamont LA, Bulmer BJ, Grimm KA, Tranquilli WJ, Sisson DD. Cardiopulmonary evaluation of the use of medetomidine hydrochloride in cats. Am J Vet Res 2001;62:1745-1749.
5. Kanda T, Hikasa Y. Neurohormonal and metabolic effects of medetomidine compared with xylazine in healthy cats. Can J Vet Res 2008;72:278-286.
6. Brown CR, Sarnquist FH, Canup CA, Pedley TA. Clinical, electroencephalographic, and pharmacokinetic studies of a water-soluble benzodiazepine, midazolam maleate. Anesthesiology 1979;50:467-470.
7. Ilkiw JE, Suter CM, Farver TB, McNeal D, Steffey EP. The behaviour of healthy awake cats following intravenous and intramuscular administration of midazolam. J Vet Pharmacol Ther 1996;19:205-216.
8. Salonen M, Reid K, Maze M. Synergistic interaction between alpha 2-adrenergic agonists and benzodiazepines in rats. Anesthesiology 1992;76:1004-1011.
9. Nishimura R, Kim H, Matsunaga S, et al. Sedative effect induced by a combination of medetomidine and midazolam in pigs. J Vet Med Sci 1993;55:717-722.
10. Itamoto K, Hikasa Y, Sakonjyu I, Itoh H, Kakuta T, Takase K. Anaesthetic and cardiopulmonary effects of balanced anaesthesia with medetomidine-midazolam and butorphanol in dogs. J Vet Med A Physiol Pathol Clin Med 2000;47:411-420.
11. Kojima K, Nishimura R, Mutoh T, Hong SH, Mochizuki M, Sasaki N. Effects of medetomidine-midazolam, acepromazine-butorphanol, and midazolam-butorphanol on induction dose of thiopental and propofol and on cardiopulmonary changes in dogs. Am J Vet Res 2002;63:1671-1679.
12. Raekallio M, Tulamo RM, Valtamo T. Medetomidine-midazolam sedation in sheep. Acta Vet Scand 1998;39:127-134.
13. Kojima K, Nishimura R, Mutoh T, et al. Comparison of sedative effects of medetomidine-midazolam, acepromazine-butorphanol and midazolam-butorphanol in dogs. Zentralbl Veterinarmed A 1999;46:141-148.
14. Itamoto K, Taura Y, Wada N, et al. Quantitative electroencephalography of medetomidine, medetomidine-midazolam and medetomidine-midazolam-butorphanol in dogs. J Vet Med A Physiol Pathol Clin Med 2002;49:169-172.
15. Nishimura R, Kim HY, Matsunaga S, et al. Effects of medetomidine-midazolam on plasma glucose and insulin concentrations in laboratory pigs. J Vet Med Sci 1994;56:559-561.
16. Sinclair MD. A review of the physiological effects of alpha2-agonists related to the clinical use of medetomidine in small animal practice. Can Vet J 2003;44:885-897.
17. Ilkiw JE, Suter CM, McNeal D, Farver TB, Steffey EP. The effect of intravenous administration of variable-dose midazolam after fixed-dose ketamine in healthy awake cats. J Vet Pharmacol Ther 1996;19:217-224.
18. Jain NC. The cat: Normal hematology with comments on response to disease. In: Jain NC, ed. Schalm's Veterinary Hematology. 4th ed. Philadelphia: Lea & Febiger, 1986:126-139.
19. Nilsfors L, Garmer L, Adolfsson A. Sedative and analgesic effects of medetomidine in dogs - an open clinical study. Acta Vet Scand Suppl 1989;85:155-159.
20. Bouloux P, Perrett D, Besser GM. Methodological considerations in the determination of plasma catecholamines by high-performance liquid chromatography with electrochemical detection. Ann Clin Biochem 1985;22(pt 2):194-203.
21. Desborough JP, Hall GM, Hart GR, Burrin JM. Midazolam modifies pancreatic and anterior pituitary hormone secretion during upper abdominal surgery. Br J Anaesth 1991;67:390-396.
22. Desborough JP, Jones PM, Persaud SJ, Howell SL. Effects of midazolam on insulin secretion from isolated rat pancreatic islets of Langerhans. Br J Anaesth 1993;70:221-222.
23. Cuparencu B, Horák J, Orbai P, Horák A, Lenghel A. The effects of the intraperitoneal administration of midazolam on blood glucose level and serum lipids in streptozotocin-induced diabetes in rats. Acta Physiol Hung 1997-1998;85:83-88.
24. Skerritt JH, Johnston GA. Enhancement of GABA binding by benzodiazepines and related anxiolytics. Eur J Pharmacol 1983;89:193-198.
25. Brice NL, Varadi A, Ashcroft SJ, Molnar E. Metabotropic glutamate and GABA(B) receptors contribute to the modulation of glucose-stimulated insulin secretion in pancreatic beta cells. Diabetologia 2002;45:242-252.
26. Dong H, Kumar M, Zhang Y, et al. Gamma-aminobutyric acid up- and downregulates insulin secretion from beta cells in concert with changes in glucose concentration. Diabetologia 2006;49:697-705.
27. Rorsman P, Berggren PO, Bokvist K, et al. Glucose-inhibition of glucagon secretion involves activation of GABAA-receptor chloride channels. Nature 1989;341:233-236.
28. Kong KL, Willatts SM, Prys-Roberts C, Harvey JT, Gorman S. Plasma catecholamine concentration during sedation in ventilated patients requiring intensive therapy. Intensive Care Med 1990;16:171-174.
29. Kallio A, Salonen M, Forssell H, Scheinin H, Scheinin M, Tuominen J. Medetomidine premedication in dental surgery - a double-blind cross-over study with a new alpha 2-adrenoceptor agonist. Acta Anaesthesiol Scand 1990;34:171-175.
30. Taouis M, Berlan M, Montastruc P, Lafontan M. Mechanism of the lipid-mobilizing effect of alpha-2 adrenergic antagonists in the dog. J Pharmacol Exp Ther 1988;247:1172-1180.
31. Vikman HL, Savola JM, Raasmaja A, Ohisalo JJ. Alpha 2A-adrenergic regulation of cyclic AMP accumulation and lipolysis in human omental and subcutaneous adipocytes. Int J Obes Relat Metab Disord 1996;20:185-189.